The Zika virus presents a serious risk for global health. Crystal structures of different constructs of the Zika virus NS2B-NS3 protease (NS2B-NS3pro) have been determined with the aim to provide a basis for rational drug discovery. In these structures, the C-terminal b-hairpin of NS2B, NS2Bc, was observed to be either disordered (open conformation) or bound to NS3pro complementing the substrate binding site (closed conformation). Enzymatically active constructs of flaviviral NS2B-NS3 proteases commonly used for inhibitor testing contain a covalent peptide linker between NS2B and NS3pro. Using a linked construct of Zika virus NS2B-NS3pro, we studied the location of NS2Bc relative to NS3pro in solution by pseudocontact shifts generated by a paramagnetic lanthanide tag attached to NS3pro. Both closed and open conformations were observed with different inhibitors. As the NS2B co-factor is involved in substrate binding of flaviviral NS2B-NS3 proteases, the destabilization of the closed conformation in the linked construct makes it an attractive tool to search for inhibitors that interfere with the formation of the enzymatically active, closed conformation.
Introduction
The Zika virus recently emerged as a major threat to global health. It is a flavivirus that depends on the activity of a viral NS2B-NS3 protease, which thus is an attractive drug target. Owing to its high sequence and structure similarity with other flaviviral NS2B-NS3 proteases, such as the West Nile virus (WNV) (Chappell et al., 2008) and dengue virus proteases, an inhibitor of the Zika virus protease could even display broad-spectrum activity against a wide range of flaviviruses (Boldescu et al., 2017) .
As full-length NS2B contains membrane-bound segments, an important advance was made when a soluble NS2B-NS3 construct was obtained for the dengue virus protease by covalently linking NS2B to the NS3 protease (NS3pro) via a covalent Gly 4 -Ser-Gly 4 linker (Leung et al., 2001) . The same approach led to soluble NS2B-NS3pro constructs of the WNV and Zika virus proteases (Nall et al., 2004; Lei et al., 2016) . These constructs are enzymatically active and widely used for activity assays . There is no general agreement, however, whether the linked NS2B-NS3pro constructs are also the most suitable constructs for drug discovery.
NS2B is essential for full enzymatic activity, but crystal structures have found NS2B in very different conformations, open and closed, depending on the presence of inhibitors binding to the active site (Erbel et al., 2006; Noble et al., 2012; Lei et al., 2016; Chen et al., 2016a; Aleshin et al., 2007; Robin et al., 2009; Chandramouli et al., 2010; Hammamy et al., 2013) . While the N-terminal segment of NS2B always forms an integral part of the b-barrel formed by NS3pro, the C-terminal part of NS2B, NS2Bc, forms a b-hairpin that tends to line the substrate binding site only in the presence of inhibitors (closed conformation), being dissociated from NS3pro in crystal structures without inhibitor (open conformation) (Erbel et al., 2006; Aleshin et al., 2007; Chen et al., 2016a; Lee et al., 2017) . In the case of the Zika virus protease, the b-hairpin of NS2Bc comprises residues 75*e87* (with the stars identifying residues of NS2B).
In solution, NMR data of the NS2B-NS3pro constructs from dengue virus, WNV and Zika virus showed NS2Bc in the closed conformation in the presence of inhibitors (Su et al., 2009; de la Cruz et al., 2011; Chen et al., 2014; Chen et al., 2016b; Zhang et al., 2016) and the closed conformation was also found in a WNV construct containing the Gly 4 -Ser-Gly 4 linker without an inhibitor (Su et al., 2009) . Solution NMR spectroscopy further indicated the closed conformation in constructs without covalent linkage between NS2B and NS3pro (Kim et al., 2013; de la Cruz et al., 2014) . In the case of the Zika enzyme, however, solution NMR experiments revealed a more complex situation. A construct produced without covalent linkage between NS2B and NS3pro (named bZiPro) displayed the closed conformation in solution and the closed conformation was also captured in the single crystal . For a related construct with an autocleavage site between NS2B and NS3pro (named eZiPro), however, the situation appears to be different in solution than in the single crystal: while the crystal structure showed the closed conformation, 15 Nrelaxation data of NS2Bc indicated high mobility in solution, characteristic of the open conformation . Although the substrate binding site in this construct was occupied by the C-terminal tetrapeptide of NS2B (residues 127e130), this was apparently not sufficient to maintain the closed conformation in solution.
Both eZiPro and bZiPro show two sets of cross-peaks for NS2B Zhang et al., 2016) which was attributed to the release of NS2B from the NS2B-NS3pro complex . Greater stability of the protease would be expected for the classical construct containing the Gly 4 -Ser-Gly 4 linker. This construct (referred to as gZiPro) has not been studied by NMR spectroscopy in the same detail as the unlinked constructs eZiPro and bZiPro. It showed no change of the NMR spectrum with the classical protease inhibitor BPTI, suggesting that the covalent linkage prevents binding of the inhibitor .
The question of open or closed conformation of the flaviviral NS2B-NS3 proteases is important for the inhibitor design. As crystalline environments can give different answers from the situation in solution, it is important to address the question by experiments under near-physiological conditions, i.e. in solution. To date, structural information on the Zika virus NS2B-NS3 protease in solution is limited to secondary structure. In this work, we investigated a chemically stable Zika virus construct containing the Gly 4 -Ser-Gly 4 linker (gZiPro) by solution NMR spectroscopy with and without inhibitors, and determined the location of NS2Bc with respect to NS3pro by the use of pseudocontact shifts (PCS) induced by a paramagnetic lanthanide tag attached to NS3pro. The results show that gZiPro is a construct that can assume both the open and closed conformation in solution, making it an attractive tool for the discovery of antiviral drugs that can target either of these conformational states.
Experimental sections

Materials
Construct design
The gene of the gZiPro construct of the ZIKV NS2B-NS3 protease used in the present work was synthesized with codon optimization for expression in E. coli (Integrated DNA Technologies), based on the amino acid sequence of the South American isolate Z1106033 (GenBank: KU312312.1; Enfissi et al., 2016) . The construct included the 48 hydrophilic core residues of NS2B (residues 48*e95*, where a star identifies NS2B residues) followed by a Gly 4 SerGly 4 linker, the 170 N-terminal residues of NS3 and a C-terminal His 6 -tag. The three mutations R95*A, K15N and R29G were introduced to eliminate potential auto-cleavage sites and increase protein stability. To allow site-specific ligation of a lanthanide tag to a single, engineered cysteine residue, the two native cysteine residues 80 and 143 were mutated to serine. Apart from the K15N and the cysteine-to-serine mutations, our construct is closely related to that used for the crystal structure 5LC0 (Lei et al., 2016) . The gene was cloned between the NdeI and EcoRI sites of the T7 vector pETMCSI (Neylon et al., 2000) . In addition, the mutant T27C was prepared for attaching a lanthanide tag to residue 27. Fig. S1 compares the amino acid sequences of our construct and previously used gZiPro constructs.
Protein sample preparation
Uniformly isotope-labelled protein was produced in E. coli BL21(DE3) using a high-cell density protocol (Sivashanmugam et al., 2009 ). Following induction with 1 mM IPTG at an OD 600 value of about 0.5e0.8, the cells were incubated overnight at 25 C. Cells were grown in M9 medium (6 g/l Na 2 HPO 4 , 3 g/l KH 2 PO 4 , 0.5 g/l NaCl) supplied with 1 g/l 15 NH 4 Cl) for uniform 15 N-labelling and in 13 C/ 15 N-labelled Spectra 9 medium (Cambridge Isotope Laboratories, Tewksbury, USA) for double-labelling. The cells were pelleted by centrifuging at 5000 g for 10 min and lysed by passing twice through a French Press (SLM Aminco, USA) at 830 bars. The cell lysate was centrifuged for 1 h at 34,000 g and supernatant was loaded on to a 5 ml Co-NTA column (GE Healthcare, USA) preequilibrated with buffer A (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5% glycerol). The protein was eluted with buffer B (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 300 mM imidazole, 5% glycerol) and fractions were analyzed by 12% SDS-PAGE. Finally, the buffer was exchanged for NMR buffer (20 mM MES, pH 6.5, 150 mM NaCl) and 10% D 2 O was added for NMR measurements. Selectively isotope-labelled protein samples and samples with site-directed mutations for resonance assignments were prepared by cell-free protein synthesis (Ozawa et al., 2004; Apponyi et al., 2008 ) and purified using a 1 ml His GraviTrap™ TALON column (GE Healthcare, USA). Cell-free synthesis enabled efficient production of selectively isotope-labelled samples (Table S1) , including samples where each of the twenty amino acids except Glu, Gln, Cys and Pro was selectively labelled with 15 N. Cell-free synthesis from PCR-amplified DNA (Wu et al., 2007) was also used to obtain sitespecific resonance assignments of all eight isoleucine residues by individual mutation to valine in eight 15 N-isoleucine-labelled samples. Similarly, the assignments of valine residues was probed by mutating 20 of 24 valine residues to isoleucine in 20 15 N-valinelabelled samples. The 15 N-labelled T27C mutant of Zika NS2B-NS3pro was tagged with lanthanide ions by incubation at 25 C overnight in the presence of three-fold excess C2 tag de la Cruz et al., 2011) . Following the tagging reaction, the samples were washed with NMR buffer using a centrifugal filter unit (Amicon Ultra, molecular weight cut-off 10 kDa; Millipore, Billerica, USA) to remove unbound tag. Fig. 1 shows the inhibitors used. Inhibitors 1 (corresponding to cn-716) and 2 (corresponding to cn-729) were synthesized as described previously . Inhibitor 3 (Lim et al., 2016) was purchased from Sigma-Aldrich. Protein samples with inhibitors were prepared by adding a 1.5-fold of excess of inhibitor 1 and 2 and a four-fold of excess of inhibitor 3.
Inhibitors
NMR spectroscopy
NMR spectra were recorded at 25 C, using 600 MHz and 800 MHz Bruker Avance NMR spectrometers equipped with cryoprobes. 3D HNCA and 3D NOESY-15 N-HSQC experiments were performed with protein concentrations of 0.5e0.8 mM in 5 mm NMR tubes. 2D NMR spectra were recorded with 0.1e0.2 mM samples in 3 mm NMR tubes.
Backbone resonance assignments
For backbone resonance assignments, the 3D HNCA and NOE-SY-15 N-HSQC spectra were supplemented by [ 15 N, 1 H]-HSQC spectra of selectively isotope-labelled samples and samples with sitedirected mutations. The assignments of NS2Bc residues were supported by recording 2D BEST-TROSY-HNCO spectra (Solyom et al., 2013) .
2.1.6. Dc-tensor fits Pseudocontact shifts (PCS), Dd PCS , were measured as the difference in amide proton chemical shifts observed in NMR spectra recorded with and without paramagnetic metal ion (in ppm). The PCSs were used to fit magnetic susceptibility anisotropy (Dc) tensors to the crystal structure coordinates using the equation
where r is the distance of the nuclear spin from the metal ion, Dc ax and Dc rh are the axial and rhombic components of the Dc tensor, and q and f are the polar angles describing the position of the nuclear spin with respect to the principal axes of the Dc tensor. The fits were performed using the program Numbat (Schmitz et al., 2008) . The quality of the fits were determined by the quality factor Q, which was calculated as the root mean square deviation between experimental and back-calculated PCSs divided by the root mean square of the experimental PCSs.
Chemical shift changes
Chemical shift changes, Dd, were calculated using the equation
where Dd H and Dd N are, respectively, the changes measured in the 
Results
NMR resonance assignments
The protein was produced in good yields of about 74 mg per litre medium in vivo and about 2 mg per mL reaction mixture in cell-free synthesis, but the NMR resonance assignments of the free protein were made difficult by a tendency for precipitation, spectral overlap and variable peak intensities for different amino acid residues. Similarly, 20 out of 24 valine residues were individually mutated to isoleucine to assign their amide cross-peaks. Finally, 2D HN(CO) spectra were recorded of eight samples selectively labelled with 15 N and 13 C (Table S1 ) to identify the [ 15 N, 1 H]-HSQC cross-peaks of individual residues following a 13 C-labelled residue (Kainosho and Tsuji, 1982) . The final assignment comprised the resonances of 174 out of 216 non-proline backbone amides (Fig. S2) . The crosspeak assignments were confirmed and supported by comparison with the assignments published for the slightly different construct eZiPro . In the course of titration with inhibitor 1, NMR signals of NS2Bc disappeared while new resonances appeared, indicating that the exchange between inhibitor-bound and free protein is slow on the NMR time scale. This was expected, as inhibitor 1 binds with low nanomolar affinity, assisted by reversible covalent bond formation of its boronate group with the active-site serine (residue 135; Lei et al., 2016) . In contrast to previous results obtained with eZiPro and bZiPro Zhang et al., 2016) , NS2B did not display a set of cross-peaks corresponding to free NS2B in the presence of inhibitor 1. Fig. 2 shows that, while many cross-peaks changed only little following addition of inhibitor 1, others displayed large changes in chemical shifts, making it necessary to obtain new resonance assignments. 2D HN(CO) spectra of the selectively 15 N-and 13 C-labelled samples used for resonance assignments of the free protein (Table S1 ) were used to assign the new cross-peaks of NS2Bc appearing after addition of inhibitor 1. The chemical shifts of these peaks proved to be close to the better dispersed set of cross-peaks reported previously for eZiPro .
NS2Bc-NS3pro association in the presence of inhibitor 1
To assess the location of NS2Bc with respect to NS3pro, we , facilitating the assignment of the paramagnetic NMR spectra (Nitsche and Otting, 2017) . PCSs with the C2-Tm 3þ tag were observed for over thirty cross-peaks (Table S2 , Fig. 3 ), which allowed determination of the magnetic susceptibility anisotropy (Dc) tensor using equation (1) ( Table S3 ). The tensor predicts PCSs of about À0.1 ppm at the site of NS2Bc, if NS2Bc were in the closed conformation as in the crystal structures (Fig. 4) . The experimentally observed PCSs of residues 55*e86* in NS2B indeed correlated closely with the predicted PCSs (Fig. 5 ), indicating that, in the presence of inhibitor 1, the closed conformation observed in the crystal structure 5LC0 is also the prevalent conformation in solution. The closed conformation was also supported by similar R 2 ( 15 N) relaxation rates observed for residues in NS2Bc and NS3pro
(data not shown). Judging by the quality factor of the Dc-tensor fits, the closed conformation of the structure 5LC0 explains the PCSs measured with inhibitor 1 better than the open conformation of the structure 5T1V (Table S3) .
NS2Bc-NS3pro association in the absence of inhibitors
To probe the conformation of gZiPro in the inhibitor-free state, we again used the PCSs generated by C2-Ln 3þ tags attached to position 27 in the T27C mutant (Fig. S3) . Good Dc-tensor fits were obtained ( Fig. S4 and Table S3 ), but while the amide cross-peaks of residues 71*, 81*, 82* and 85* of NS2B could be observed in the presence of the diamagnetic C2-Y 3þ tag, they disappeared in the presence of a paramagnetic C2 tag. The effect can be explained by excessive line broadening due to dislocation of NS2Bc from its usual site on NS3pro. This dislocation could bring NS2Bc into proximity of the paramagnetic tags where it would be exposed to paramagnetic relaxation enhancements. attached at position 27. The isosurfaces correspond to PCSs of 1 ppm (dark blue), 0.1 ppm (light blue), À1 ppm (dark red) and À0.1 ppm (light red), and are plotted on the crystal structure of the Zika virus NS2B-NS3 protease in complex with inhibitor 1 (PDB ID: 5LC0). The metal position is shown as a magenta sphere and the C a atom of the tag attachment site is indicated by a green sphere. The inhibitor 1 is represented by a stick representation. 31 residues, indicated by a dotted line and including the Gly 4-SerGly 4 linker, connect the C-terminus of NS2B with the N-terminus of NS3pro, but no coordinates are reported for these disordered residues in the crystal structure. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
smaller than for NS3pro (data not shown). Much slower relaxation rates in NS2Bc versus NS3pro have similarly been reported for the eZiPro construct . In addition, the chemical shifts of all assigned amide protons of NS2Bc were in the range of 7.6e8.6 ppm, which is characteristic of chemical shifts in flexibly disordered proteins. The chemical shifts were also close to those reported by Zhang et al. (2016) for free NS2B peptide. Therefore, the gZiPro construct used in this work assumes an open conformation in solution, if no high-affinity inhibitor is present.
Complexes with inhibitors 2 and 3
Titration with the inhibitor 2, which differs from inhibitor 1 by an additional t-butyl group and an alternative basic P 2 side chain (Fig. 1) , led to the disappearance of the cross-peaks of NS2Bc and of many of the NS3pro resonances, suggesting excessive broadening by chemical exchange in the intermediate time regime (Fig. S5) . This result indicates that the structure of the complex is destabilized by the steric clash between the t-butyl group and the loop comprising residues 154e161 in NS3pro, which is predicted by the crystal structure 5LC0. Previously reported IC 50 values of inhibitor 2 versus inhibitor 1 indicated weaker binding of inhibitor 2 (2.1 versus 0.25 mM; . While the 1 H-NMR signal of the t-butyl group of inhibitor 2 could readily be observed in the complex with the dengue virus protease (Chen et al., 2016b) , it was too broad to be resolved in the complex with the Zika virus protease.
Titration with the inhibitor 3 also produced chemical shift changes and line-broadening effects (Fig. S6) . The inhibitor binds in slow exchange. Signals of His51 and Tyr130 in the substrate binding site disappeared, and chemical shift changes were observed not only near the substrate binding site but also on the far side of the protease (Fig. 6A) . A wide distribution of chemical shift changes was also observed with inhibitor 1, which is known to bind at the active site (Fig. 6B) . Therefore, the data suggest that inhibitor 3, which is active against a range of different serine proteases, binds at the active site and the chemical shift changes observed elsewhere in the protease reflect allosteric conformational changes. There is no evidence, however, that inhibitor 3 induces the closed conformation, as the chemical shifts of residues in NS2Bc remained unaffected (Fig. S7 ).
Discussion
Six different crystal structures of the Zika virus protease have been published and all but two of them show the closed conformation, irrespective of the presence or absence of ligands in the substrate binding site (Lei et al., 2016; Zhang et al., 2016) , with no electron density observed for NS2Bc in the open conformation (Chen et al., 2016a; Lee et al., 2017) . A different (Erbel et al., 2006; Aleshin et al., 2007; Chandramouli et al., 2010) . In the case of the Zika virus protease, the state of NS2Bc in solution has been addressed by relaxation experiments performed by NMR spectroscopy, indicating that NS2Bc is associated with NS3pro in the construct bZiPro, which has no covalent linkage between NS2B and NS3 . Similarly, in the absence of a linker peptide connecting NS2B and NS3, the closed state has earlier been reported for the dengue virus protease (Kim et al., 2013; de la Cruz et al., 2014) . Unexpectedly, however, much slower relaxation rates for NS2Bc than NS3pro were reported for the autoproteolytically cleaved construct eZiPro, indicating dissociation of NS2Bc from NS3pro . The authors did not report which of the two sets of cross-peaks observed for NS2B were used for relaxation measurements. The present work used pseudocontact shifts in order to assess the actual location of NS2Bc in a linked gZiPro construct of the Zika virus protease in solution. While PCSs were predicted for NS2Bc in the closed conformation and, in fact, observed in the presence of The open conformation is most likely promoted by the artificial linker between NS2B and NS3pro. In the wild-type enzyme, no such linkage exists due to an autoproteolytic cleavage site. Formally, the linker in gZiPro is represented by only nine residues (Gly 4 SerGly 4 ), which should not be able to span the distance between the last residue of NS2B and the first residue of NS3 observed in the crystal structures (about 45 Å, see Fig. 4) . Notably, however, none of the crystal structures report electron density for the N-terminal 14 residues of NS3 and flexible disorder of the 17 N-terminal residues was also indicated by greatly reduced R 2 ( 15 N) and increased R 1 ( 15 N) relaxation rates in the unlinked construct eZiPro . These residues must thus be included in the flexible link between NS2B and NS3. In fully extended conformation, 31 residues could span over 100 Å. As NS2Bc binds only weakly to NS3pro, the open conformation appears as a possible target for an inhibitor that, by preventing formation of the closed conformation, greatly diminishes the activity of the protease. By biasing the equilibrium between open and closed conformation towards the open state, the gZiPro construct could be uniquely suited to probe whether an inhibitor induces the closed conformation or binds to the open conformation. For quantitative measurements of dissociation constants, gZiPro also has the distinctive advantage of not releasing NS2B into the solution, in contrast to the constructs eZiPro and bZiPro. The relevance of gZiPro as a research tool has very recently been demonstrated by the identification of bromocriptine as an inhibitor of the Zika virus protease with similar activity both in biochemical and cellular assays (Chan et al., 2017) .
